v3.26.3
Intangible Assets
9 Months Ended
Sep. 30, 2026
Intangible Asset, Goodwill and Other [Abstract]  
Intangible Assets

Note 6. Intangible Assets

 

The definite-lived intangible assets, to be amortized between 1 and 20 years, balances, and activity for the nine months ended September 30, 2026 and year ended December 31, 2025 consisted of the following:

 

      September 30, 2026
(unaudited)
   December 31, 2025 
   Useful Life  Gross
Carrying
Amount
   Accumulated
Amortization
   Net
Carrying
Amount
   Gross
Carrying
Amount
   Accumulated
Amortization
   Net
Carrying
Amount
 
Developed technology assets  20 years  $22,260,000   $6,401,000   $15,859,000   $22,260,000   $5,566,000   $16,694,000 
Acquired assets  1 -17 years   325,000    44,000    281,000    325,000    25,000    300,000 
      $22,585,000   $6,445,000   $16,140,000   $22,585,000   $5,591,000   $16,994,000 

 

 

Impact Biomedical, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

 

 

 

Amortization expense for the nine months ended September 30, 2026 and 2025 was approximately $853,000 and $855,000, respectively.

 

The following table represents future amortization of developed technologies for the years ending December 31:

 

      
2026  $239,000 
2027  $1,138,000 
2028  $1,130,000 
2029  $1,130,000 
2030  $1,130,000 
thereafter  $11,373,000